Home > News > Q Chip seals deal with leading biotech firm
December 28th, 2004
Q Chip seals deal with leading biotech firm
Abstract:
Cardiff-based Q Chip has agreed the joint venture with FTSE techMark 100-listed Biocompatibles International, a medical device company which is focused on the treatment of cardiovascular disease, cancer and benign tumours.
The Welsh company possesses technology which enables the production of uniform particles at a molecular level. It uses tiny capillaries etched in wafers to precisely create micro and nanoparticles.
Source:
icwales
Related Links |
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||